The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation - Trullas-Jimeno, A; Delgado, J; Garcia-Ochoa, B; Wang, I; Sancho-Lopez, A; Payares-Herrera, C; Dalhus, M L; Strom, B O; Egeland, E J; Enzmann, H; Pignatti, F (ESMO OPEN, 2021)